Ocean Biomedical Inc.

NASDAQ: OCEA · Real-Time Price · USD
0.01
0.00 (26.58%)
At close: Jun 09, 2025, 3:19 PM

Ocean Biomedical Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
n/a -2.48M -62.34M
Interest Income
n/a 1.52M 2.45K
Pretax Income
-3.3M -958.43K -62.34M
Net Income
-3.3M 565.47K -62.34M
Selling & General & Admin
3.77M 2.48M 28.41M
Research & Development
26K n/a 33.93M
Other Expenses
n/a n/a 1K
Operating Expenses
3.8M 2.48M 62.34M
Interest Expense
-2.05M 691.00 n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
n/a 2.48M 62.34M
Income Tax Expense
n/a n/a -236.56K
Shares Outstanding (Basic)
27.5M 19.02M 13.22M
Shares Outstanding (Diluted)
27.5M 19.02M 13.22M
EPS (Basic)
-0.12 0.03 -4.71
EPS (Diluted)
-0.12 0.03 -4.71
EBITDA
n/a -957.74K -564.11K
EBIT
n/a -957.74K -564.11K
Depreciation & Amortization
n/a n/a 236.56K